The What, the Why, and the How of HIV Treatment Initiation

Reviewed by Jacob Lalezari, MD

A CEU-accredited, special-topic slide set

Expired: November 12, 2009

The What, the Why, and the How of HIV Treatment Initiation is the second in the popular series of Visionary Health Concepts’ special topic slide-sets that assist in improving patient/provider communication and patient health literacy on HIV- and hepatitis-related topics.

Please review the CE information, then click on the button below to register to view the slides (registration is required to view slide content). The slides are available in 2 formats: PowerPoint slides (with speaker’s notes) and Flash (with audio voiceover of speaker’s notes).

Joint Sponsor

This activity is joint sponsored by Visionary Health Concepts and Medical Education Collaborative (MEC). MEC is a non-profit organization that has been certifying quality educational activities since 1988.

Disclaimer: The opinions expressed in this educational activity are those of the faculty and do not reflect the views of Medical Education Collaborative and Visionary Health Concepts. This educational activity may discuss off-label and/or investigational uses and dosages for therapeutic products/procedures that have not been approved by the United States Food and Drug Administration (FDA). Medical Education Collaborative and Visionary Health Concepts do not recommend the use of any product/procedure outside of the labeled indications. A qualified health care professional should be consulted before using any therapeutic product/procedure discussed. All readers and continuing education participants should verify all information and data before treating patients or employing any therapies described in this continuing education activity. Please refer to the official prescribing information for each product/procedures for approved indication, contraindications, and warnings.

Accreditation Statement(s): ANCC

Medical Education Collaborative (MEC) is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.

This continuing nursing education activity for 1.0 contact hour(s) is provided by MEC.

Medical Education Collaborative (MEC) is approved by the California Board of Registered Nursing, Provider Number 12990 for 1.0 contact hour(s).

For questions regarding the accreditation of this activity, please contact Medical Education Collaborative at (303) 420-3252 or inquire@meccme.org.

Faculty Disclosures

The planning committee and faculty members have the following disclosures:

CE Chairperson

Jacob Lalezari, MD

Medical Director

Quest Clinical Research

Assistant Clinical Professor of Medicine

University of California, San Francisco

Jacob Lalezari, MD has the following relationships to disclose: research support for Boehringer Ingelheim; research and consultant for GlaxoSmithKline, Panacos, Pfizer, Roche and Tibotec Therapeutics.

Editors

Deneen Robinson

Savant Consultants

Dallas, TX

Deneen Robinson has the following relationships to disclose: stock ownership: Abbott Laboratories; advisory committee: Bristol-Myers Squibb; speaker’s bureau: Gilead Sciences.

Maggie Sosa, APRN, BC, AACRN, ACHPNNP

Nurse Practitioner

Broadway House for Continuing Care

Newark, NJ

Maggie Sosa has no relationships to disclose.

Writer, Editor-in-Chief

Lillian Thiemann

President

Visionary Health Concepts

Gardiner, NY

Lillian Thiemann has no relationships to disclose.

Accredited Provider

The employees of Medical Education Collaborative, the accredited provider for this activity, have no significant relationships to disclose.

Target Audience

This program is intended for nurse practitioners and other healthcare providers treating HIV-positive patients. Participants should have a basic knowledge of HIV disease and its treatment.

Learning Objectives

Upon completion of this educational activity, participants should be able to:

· Explain what is meant by easy-to-understand language of treatment messages to increase patient-provider

communications

· Utilize simple sentences, analogies and visual graphics to increase health literacy among patients during counseling

sessions prior to the initiation of HIV treatment

· Outline current guidelines for the treatment of naïve HIV patients and how to clearly communicate treatment options to

patients to determine which antiretrovirals to use to avoid treatment failure

Purpose Statement

The purpose of this activity is to increase the knowledge and competency of nurse practitioners in utilizing health literacy techniques to communicate important educational messages to patients and to heighten the effectiveness of pre-treatment counseling for the treatment naïve HIV patients.

Release & Expiration Dates

Release date: November 12, 2008; Expiration date: November 12, 2009

Instructions for Credit

Read the target audience, objectives, faculty disclosures, accreditation statements, and commercial supporters then click on “Register to View Program”. This will take you to the content page, where you can access the content by choosing the “Flash Slide Set” or “PowerPoint Slide Set”. To receive credit, it is required to 1). read each slide and 2). read the accompanying speaker’s notes for each slide (PowerPoint version) or listen to the audio of the speaker’s notes (Flash version) that accompanies each slide. Upon finishing the content, complete the CME Post Test, Course Evaluation and Credit Application online to receive your certificate. You must receive a test score of at least 75% and respond to all evaluation questions to receive a certificate. CE certificates will be mailed approximately 6-8 weeks after submission. There are no costs/fees for this activity.

Hardware/Software requirements:

An Internet connection that is least 56.6 Kbps; a monitor set to 800x600 pixels or more; Netscape 7.x or newer, Internet Explorer 5.x or newer, or Firefox; Macromedia Flash plug-in 7.0 or greater; Adobe Acrobat Reader; Microsoft PowerPoint; (Optional) Sound card and speakers for audio.

Commercial Support

This activity was made possible by an unrestricted educational grant from Bristol-Myers Squibb.

Privacy Statement

Medical Education Collaborative (MEC) protects the privacy of personal and other information regarding participants, educational partners, and joint sponsors. MEC and our joint sponsors will not release personally identifiable information to a third party without the individual’s consent, except such information as is required for reporting purposes to the appropriate accrediting agency.

Medical Education Collaborative (MEC) and Visionary Health Concepts maintain physical, electronic and procedural safeguards that comply with federal regulations to guard your nonpublic personal information.

Release Date: November 12, 2008; Expiration Date: November 12, 2009

I have reviewed the required CE information.